Frank Frantzen
Technik-/Wissenschafts-/F&E-Leiter bei CardiNor AS
Profil
Frank Frantzen is currently the Chief Technology Officer at CardiNor AS.
Prior to this, he worked as the Senior Director of Research and Development at Abbott Norge AS and as a Director at Gentian Diagnostics ASA. Frantzen holds a graduate and doctorate degree from the Norwegian University of Science & Technology.
Aktive Positionen von Frank Frantzen
| Unternehmen | Position | Beginn |
|---|---|---|
CardiNor AS
 CardiNor AS BiotechnologyHealth Technology CardiNor AS develops, produces, and sells in-vitro diagnostic products. It establishes a blood test for elevated levels of Secretoneurin that may indicate that a patient has a heart disease. The company was founded on June 25, 2015 and is headquartered in Oslo, Norway. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ehemalige bekannte Positionen von Frank Frantzen
| Unternehmen | Position | Ende |
|---|---|---|
| GENTIAN DIAGNOSTICS | Direktor/Vorstandsmitglied | 18.12.2023 |
Abbott Norge AS
 Abbott Norge AS Pharmaceuticals: MajorHealth Technology Abbott Norge AS researches, markets, and trades pharmaceuticals and laboratory diagnostics. The company was founded on March 12, 1990 and is headquartered in Fornebu, Norway. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2021 |
Ausbildung von Frank Frantzen
| Norwegian University of Science & Technology | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| GENTIAN DIAGNOSTICS | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Abbott Norge AS
Abbott Norge AS Pharmaceuticals: MajorHealth Technology Abbott Norge AS researches, markets, and trades pharmaceuticals and laboratory diagnostics. The company was founded on March 12, 1990 and is headquartered in Fornebu, Norway. | Health Technology |
CardiNor AS
CardiNor AS BiotechnologyHealth Technology CardiNor AS develops, produces, and sells in-vitro diagnostic products. It establishes a blood test for elevated levels of Secretoneurin that may indicate that a patient has a heart disease. The company was founded on June 25, 2015 and is headquartered in Oslo, Norway. | Health Technology |
